| Literature DB >> 28793334 |
Trillitye Paullin1, Chase Powell1, Christopher Menzie1, Robert Hill1, Feng Cheng2,3, Christopher J Martyniuk4, Sandy D Westerheide1.
Abstract
Ovarian cancer is the most lethal gynecological cancer, with over 200,000 women diagnosed each year and over half of those cases leading to death. These poor statistics are related to a lack of early symptoms and inadequate screening techniques. This results in the cancer going undetected until later stages when the tumor has metastasized through a process that requires the epithelial to mesenchymal transition (EMT). In lieu of traditional monolayer cell culture, EMT and cancer progression in general is best characterized through the use of 3D spheroid models. In this study, we examine gene expression changes through microarray analysis in spheroid versus monolayer ovarian cancer cells treated with TGFβ to induce EMT. Transcripts that included Coiled-Coil Domain Containing 80 (CCDC80), Solute Carrier Family 6 (Neutral Amino Acid Transporter), Member 15 (SLC6A15), Semaphorin 3E (SEMA3E) and PIF1 5'-To-3' DNA Helicase (PIF1) were downregulated more than 10-fold in the 3D cells while Inhibitor Of DNA Binding 2, HLH Protein (ID2), Regulator Of Cell Cycle (RGCC), Protease, Serine 35 (PRSS35), and Aldo-Keto Reductase Family 1, Member C1 (AKR1C1) were increased more than 50-fold. Interestingly, EMT factors, stress responses and epigenetic processes were significantly affected by 3D growth. The heat shock response and the oxidative stress response were also identified as transcriptome responses that showed significant changes upon 3D growth. Subnetwork enrichment analysis revealed that DNA integrity (e.g. DNA damage, genetic instability, nucleotide excision repair, and the DNA damage checkpoint pathway) were altered in the 3D spheroid model. In addition, two epigenetic processes, DNA methylation and histone acetylation, were increased with 3D growth. These findings support the hypothesis that three dimensional ovarian cell culturing is physiologically different from its monolayer counterpart.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28793334 PMCID: PMC5549971 DOI: 10.1371/journal.pone.0182930
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Establishment of three-dimensional mesenchymal cell populations from confluent monolayers.
A) HEY cells grown in a monolayer are released and then suspended in drops of culture media containing TGFβ (20,000 cells per drop) using the hanging drop method. After 72 hours, the resulting 3D spheroids are then assayed. B) Image of HEY cells grown in monolayer culture. C) Image of HEY cells grown as a 3D spheroid and treated with TGFβ.
Fig 2HEY cells treated with TGFβ have distinct gene expression profiles when grown as 3D spheroids vs. 2D monolayers.
A) Hierarchical clustering of expression profiles. Clustering revealed that each of the two groups (4 biological replicates per group) form into distinct clades based on expression. B) Principle component analysis for expression profiles. Variability in transcriptome response separates strongly along the first PCA1. Red color is HEY 3D biological replicates and green color is HEY 2D biological replicates. The four biological replicates for HEY 2D are more closely related in expression as compared to HEY 3D.
Fig 3Real time PCR analysis validates microarray results.
A) Real time PCR results for select genes that are moderately to highly affected by 3D vs. 2D growth. B) Microarray results are plotted for the same genes.
The most differentially expressed transcripts in the HEY 3D compared to HEY 2D.
| Down-regulated | CCDC80 | Heparin binding and fibronectin binding | -17.39 | 2.87E-09 |
| SLC6A15 | Amino acids transport | -14.75 | 2.3E-08 | |
| SEMA3E | Axon guidance ligands | -14.67 | 9.33E-09 | |
| TENM2 | Protein homodimerization activity | -13.71 | 7.28E-10 | |
| PLCB4 | Catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol | -13.13 | 2.43E-08 | |
| MIR17 | Involved in cancer and cell carcinomas | -13.09 | 2.91E-08 | |
| PIF1 | 5' to 3' DNA helicase | -13.02 | 1.09E-08 | |
| IL1RAP | Associates with interleukin to mediate NF-κB signaling | -11.49 | 1.16E-08 | |
| GPR126 | G-protein orphan receptor | -10.83 | 6.66E-09 | |
| FBN2 | Component of connective tissue microfibrils | -10.45 | 2.36E-08 | |
| MIR1304 | mRNA regulation | -9.92 | 1.22E-08 | |
| TRMT13 | Methyltransferase activity | -9.22 | 7.77E-09 | |
| DLEU2 | Associated with chronic lymphocytic leukemia | -9.09 | 4.32E-09 | |
| TIGD1 | Unknown | -8.98 | 6.51E-08 | |
| TPM1 | Involved in the contractile system of striated and smooth muscles | -8.91 | 9.32E-08 | |
| KRTAP2 | Formation of a rigid and resistant hair shaft | -8.78 | 4.61E-09 | |
| RIMS2 | Ion channel binding and Rab GTPase binding | -8.77 | 6.88E-10 | |
| ATP8B1 | Transport of phosphatidylserine and phosphatidylethanolamine | -8.60 | 7.27E-10 | |
| AHNAK2 | Cell differentiation | -8.56 | 8.9E-09 | |
| AKAP12 | Scaffold protein in signal transduction | -8.08 | 5.87E-09 | |
| Up-regulated | MRPS6 | Protein synthesis in mitochondria | 18.96 | 5.7E-10 |
| TNFSF15 | Cytokine inducible by TNF and IL-1α | 20.18 | 2.85E-08 | |
| RANBP3L | Binding protein | 20.29 | 3.27E-09 | |
| SLC1A3 | Termination of excitatory neurotransmission in central nervous system | 22.47 | 1.07E-09 | |
| TMEM171 | Unknown | 24.17 | 7.76E-10 | |
| AKR1B1 | Catalyzes the reduction of aldehydes | 24.76 | 4.53E-10 | |
| F2RL1 | Receptor for trypsin and trypsin-like enzymes coupled to G proteins | 25.68 | 5.85E-10 | |
| S100A4 | Cell cycle progression and differentiation | 28.15 | 5.7E-10 | |
| PTGS2 | Prostaglandin biosynthesis | 29.55 | 3.06E-08 | |
| SOD2 | Converts superoxide byproducts to H2O2 | 32.39 | 4.72E-09 | |
| CXCR4 | CXC chemokine receptor | 35.08 | 6.24E-10 | |
| IL8 | Neutrophil chemotactic factor | 55.81 | 7.76E-10 | |
| SPOCK1 | Protease inhibition | 56.98 | 6.76E-10 | |
| NADK2 | Catalyzes the phosphorylation of NAD to yield NADP | 57.98 | 2.16E-08 | |
| GLS | Catalyzes the hydrolysis of glutamine to glutamate | 59.61 | 6.06E-08 | |
| ITGB8 | Mediate cell-cell and cell-extracellular matrix interactions | 60.23 | 2.1E-09 | |
| ID2 | Cellular growth, senescence, differentiation, apoptosis, angiogenesis | 70.77 | 4.63E-09 | |
| RGCC | Regulates cell cycle, induced by p53 | 78.93 | 5.85E-10 | |
| PRSS35 | Protease activity | 179.46 | 5.85E-10 | |
| AKR1C1 | Conversion of aldehydes and ketones to their corresponding alcohols | 198.09 | 5.7E-10 |
Transcripts are organized as those down-regulated and up-regulated between the two groups. The gene, as well as the role of the protein in the cell is provided in addition to the relative fold change and p-value. For a complete list of gene expression changes see S2 Table.
Examples of cell processes differentially expressed between HEY 2D and HEY 3D cells.
| Autophagy | autophagy | 418 | 402 | 1.08 | 5.9E-06 |
| autophagic cell death | 78 | 75 | 1.15 | 0.00076 | |
| Cancer and Aging | senescence | 651 | 596 | 1.05 | 7.79E-08 |
| cell aging | 251 | 225 | 1.06 | 2.1E-07 | |
| oncogenesis | 523 | 486 | 1.05 | 1.36E-05 | |
| epithelial to mesenchymal transition | 551 | 522 | -1.0087 | 1.99E-07 | |
| Cell Cycle | S phase | 857 | 797 | 1.05 | 4.38E-09 |
| interphase | 196 | 192 | -1.05 | 1.13E-08 | |
| G1/S transition | 611 | 558 | 1.07 | 1.73E-06 | |
| G2 phase | 171 | 164 | 1.07 | 2.51E-05 | |
| cell cycle checkpoint | 161 | 150 | 1.06 | 4.1E-05 | |
| exit from mitosis | 62 | 59 | 1.06 | 0.000284 | |
| Chromosome Separation | spindle assembly | 507 | 478 | -1.06 | 1.14E-11 |
| centriole duplication | 106 | 103 | -1.10 | 6.98E-07 | |
| mitotic spindle assembly | 59 | 58 | -1.18 | 2.98E-05 | |
| microtubule/kinetochore interaction | 19 | 19 | -1.54 | 0.000872 | |
| DNA Damage and Repair | response to DNA damage | 460 | 428 | 1.07 | 1.32E-12 |
| DNA repair | 654 | 609 | 1.05 | 1.3E-10 | |
| genome instability | 292 | 272 | 1.06 | 4.09E-08 | |
| genetic instability | 113 | 111 | 1.08 | 3.76E-07 | |
| nucleotide-excision repair | 120 | 113 | 1.09 | 7.58E-06 | |
| DNA damage checkpoint | 126 | 122 | 1.06 | 6.2E-05 | |
| Protein Modification | protein degradation | 470 | 449 | 1.06 | 7E-08 |
| ubiquitin-dependent protein degradation | 193 | 186 | 1.16 | 1.23E-05 | |
| protein ubiquitination | 89 | 88 | 1.15 | 3.27E-05 | |
| protein sumoylation | 167 | 158 | 1.13 | 4.71E-05 | |
| Stress | response to oxidative stress | 166 | 159 | 1.06 | 3.55E-05 |
| heat-shock response | 65 | 59 | 1.14 | 0.000722 | |
| Transcription | poly(A)+ mRNA-nucleus export | 84 | 77 | -1.13 | 9.86E-05 |
| Polymerase II transcription | 75 | 70 | 1.13 | 0.000393 | |
| Other | adipocyte differentiation | 394 | 367 | 1.06 | 5.11E-06 |
| wall integrity | 51 | 51 | 1.37 | 5.74E-06 | |
| myoblast differentiation | 212 | 196 | 1.08 | 1.85E-05 | |
| nucleocytoplasmic transport | 122 | 112 | 1.10 | 2E-05 | |
| adherens junction assembly | 52 | 50 | 1.12 | 2.79E-05 | |
| skin development | 69 | 67 | 1.10 | 0.000175 | |
| blood vessel barrier | 28 | 28 | 1.26 | 0.000545 | |
| leiomyocyte adhesion | 25 | 24 | -1.14 | 0.000756 |
Provided are the total number of neighbors within a network, number of neighbors measured on the microarray, the median fold change of the network, and the p-value. All cell processes differentially expressed between cells are provided in S3 Table. Major themes included those related to cell cycle, DNA damage and repair, and stress.
Fig 4Expression of genes related to EMT in 3D vs. 2D growth.
All these genes in the pathway were differentially expressed at P<0.001 in 3D and are related to the process of EMT. Red indicates the gene is up-regulated and blue indicates the gene is down-regulated. All genes for pathways are listed in S4 Table.
Fig 5Gene networks related to stress are significantly enriched following sub-network enrichment analysis when comparing 3D vs. 2D growth.
Red indicates the gene is upregulated and blue indicates the gene is downregulated. All genes for the pathways are listed in S4 Table.
Fig 6DNA methylation was significantly enriched following sub-network enrichment analysis when comparing 3D vs. 2D growth.
DNA methylation was preferentially increased approximately 4% (197 genes measured, P = 0.006) in the 3D group at the level of the transcriptome based on the sub-network enrichment analysis. Red indicates the gene is up-regulated and blue indicates the gene is down-regulated. All genes for DNA methylation are listed S4 Table.
Fig 7Pathway for histone acetylation.
A number of histone modifying enzymes were increased in expression in the 3D group, and this may be reflective of chromatin remodeling during cancer progression. Red indicates the gene or process is up-regulated and blue indicates the gene or process is down-regulated. All genes for histone acetylation pathways are listed in S4 Table.